Disclosures for "Towards a Standardized Process of Onboarding Advanced Practice Providers into Headache Medicine Practices in the United States"
-
Dr. Freeman has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Southern Headache Society . The institution of Dr. Freeman has received research support from AbbVie. The institution of Dr. Freeman has received research support from Biohaven. The institution of Dr. Freeman has received research support from Lundbeck. The institution of Dr. Freeman has received research support from Satsuma. The institution of Dr. Freeman has received research support from Pfizer. The institution of Dr. Freeman has received research support from Ipsen.
-
Dr. Cook has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Cook has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allergan. Dr. Cook has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer . Dr. Cook has a non-compensated relationship as a Board Member with Alliance for Patient Access that is relevant to AAN interests or activities.
-
Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Ailani has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Ailani has received personal compensation in the range of $0-$499 for serving as a Consultant for Gore. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merz. Dr. Ailani has received personal compensation in the range of $0-$499 for serving as a Consultant for Scilex. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dr. Reddy. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vectura. Dr. Ailani has received personal compensation in the range of $0-$499 for serving as a Consultant for Aeon. Dr. Ailani has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Linpharma. Dr. Ailani has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aeon. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Self Magazine. The institution of Dr. Ailani has received research support from Ipsen. The institution of Dr. Ailani has received research support from Parema. The institution of Dr. Ailani has received research support from Lundbeck. Dr. Ailani has a non-compensated relationship as a Executive Board Member with American Headache Society that is relevant to AAN interests or activities.
-
Ms. Ehrlich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie Pharmaceuticals. Ms. Ehrlich has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. Ms. Ehrlich has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eli Lilly. Ms. Ehrlich has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Ms. Ehrlich has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Headache Cooperative of the Pacific. Ms. Ehrlich has received personal compensation in the range of $500-$4,999 for serving as a Meditation teacher with Miles for Migraine. Ms. Ehrlich has a non-compensated relationship as a Working Group Member with Alliance for Patient Access that is relevant to AAN interests or activities. Ms. Ehrlich has a non-compensated relationship as a Board member with Alliance for Headache Disorders Advocacy that is relevant to AAN interests or activities. Ms. Ehrlich has a non-compensated relationship as a Medical reviewer (volunteer) with Migraine Again that is relevant to AAN interests or activities.
-
Dr. Grosberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Grosberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. Dr. Grosberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Grosberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Linpharma pharmaceuticals. Dr. Grosberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Grosberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Theranica . Dr. Grosberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biohaven. Dr. Grosberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Grosberg has stock in Theranica. The institution of Dr. Grosberg has received research support from Theranica. The institution of Dr. Grosberg has received research support from Amgen. The institution of Dr. Grosberg has received research support from Abbvie. The institution of Dr. Grosberg has received research support from Eli Lilly. The institution of Dr. Grosberg has received research support from Teva. The institution of Dr. Grosberg has received research support from Neurolief. Dr. Grosberg has received publishing royalties from a publication relating to health care.
-
Dr. Samaha has received personal compensation in the range of $500-$4,999 for serving as a Consultant for theranica. Dr. Samaha has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for AAN . The institution of Dr. Samaha has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for AAP.
-
Dr. Moriarty has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Moriarty has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Moriarty has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Moriarty has received research support from Teva.
-
Ms. Secora has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie Inc. Ms. Secora has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Impel Pharmaceuticals Inc..
-
Dr. VanderPluym has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Neurology and Neuroscience Reports. The institution of Dr. VanderPluym has received research support from Amgen.
-
Dr. Birlea has nothing to disclose.